Plain-English translation of NCT07098065 on ClinicalTrials.gov ↗ ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether showing smokers graphic health warnings—pictures and information about smoking's harms—along with one-on-one counseling from a pharmacist can help them quit smoking. The study will compare three approaches: graphic warnings alone, graphic warnings plus pharmacist counseling, and standard pharmacy care. Researchers want to see which approach works best and is most cost-effective in South Asia.
Smoking remains very common in Bangladesh and Pakistan and causes serious diseases like heart problems, high blood pressure, and cancer. Pharmacists are trusted and easy to reach in their communities, but they're rarely used to help people quit smoking. This trial tests whether combining visual health warnings with personalized support from a pharmacist can fill this gap and help more people succeed in quitting.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly placed into one of three groups. Some participants will receive graphic health warning booklets to take home; others will get those same materials plus two counseling sessions with a pharmacist (at the start and at 6 months), along with monthly reminder text messages; and a third group will receive standard pharmacy care. All participants will be checked in at 12 months to see whether they've quit smoking or reduced the number of cigarettes they smoke.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Bangladesh